Owen DSR Capsule is a combination pharmaceutical formulation containing Domperidone 30 mg and Pantoprazole 40 mg, designed to manage gastrointestinal disorders characterized by acid reflux and delayed gastric emptying. Domperidone, a peripheral dopamine D2 receptor antagonist, enhances gastrointestinal motility by increasing the movement of the stomach and intestines, thereby facilitating gastric emptying and reducing symptoms such as nausea and vomiting. Pantoprazole, a proton pump inhibitor (PPI), suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, leading to a significant reduction in gastric acidity. The combined action of these agents provides symptomatic relief in conditions such as gastroesophageal reflux disease (GERD), erosive esophagitis, and functional dyspepsia. Owen DSR Capsule is typically prescribed for patients experiencing upper gastrointestinal discomfort, heartburn, acid regurgitation, and delayed gastric emptying. It is important to use this medication under medical supervision, considering contraindications such as known hypersensitivity to either component, and to monitor for potential side effects including headache, dry mouth, abdominal cramps, or rare extrapyramidal symptoms. Dosage adjustments may be necessary in patients with hepatic impairment. This combination therapy offers an effective approach to managing complex gastrointestinal symptoms by addressing both acid suppression and motility enhancement.